Tenofovir Douche as HIV Preexposure Prophylaxis for Receptive Anal Intercourse: Safety, Acceptability, Pharmacokinetics, and Pharmacodynamics (DREAM 01)

By sjmartinez • April 15, 2024

Weld ED, McGowan I, Anton P, Fuchs EJ, Ho K, Carballo-Dieguez A, Rohan LC, Giguere R, Brand R, Edick S, Bakshi RP, Parsons T, Manohar M, Seigel A, Engstrom J, Elliott J, Jacobson C, Bagia C, Wang L, Al-Khouja A, Hartman DJ, Bumpus NN, Spiegel HML, Marzinke MA, Hendrix CW. Tenofovir Douche as HIV Preexposure Prophylaxis for Receptive Anal Intercourse: Safety, Acceptability, Pharmacokinetics, and Pharmacodynamics (DREAM 01). J Infect Dis. 2024 Apr 12;229(4):1131-1140. doi: 10.1093/infdis/jiad535. PMID: 38019657; PMCID: PMC11011183.

Tags: Digestive Diseases, HIV, Microbicide, Pharmacodynamics, Pharmacokinetics, phase 1, preexposure prophylaxis, Publications

Interaction between haploinsufficiency of PTPN2 and patient microbiome promotes autoimmune arthritis in mice

Sendo S, Vela AJ, Ro M, Thiruppathy D, Wilkinson EL, Zhao Z, Hsieh WC, Yang S, Coras R, Bergot AS, Guma M, Nguyen A, McBride[...]

Extraintestinal symptoms in irritable bowel syndrome are associated with stress reactivity and the gut microbiome in a sex-dependent manner

Jacobs JP, Labus JS, Dong TS, Shin AS; UCLA SCORE Group in IBS and Sex Differences; Mayer EA, Chang L. Extraintestinal symptoms in irritable bowel[...]

Colonoscopic Follow-up After Abnormal Blood-Based Colorectal Cancer Screening Results

Zaki TA, Zhang NJ, Forbes SP, Raymond VM, Das AK, May FP. Colonoscopic Follow-up After Abnormal Blood-Based Colorectal Cancer Screening Results. Gastroenterology. 2025 Jul 21:S0016-5085(25)05775-0.[...]